期刊
CURRENT BLADDER DYSFUNCTION REPORTS
卷 14, 期 2, 页码 31-40出版社
SPRINGER
DOI: 10.1007/s11884-019-00504-z
关键词
Urine; BPH; Prostatic inflammation and chemokines
资金
- NIDDK grant [U54 DK112079]
Purpose of Review Benign prostatic hyperplasia (BPH) is a common age-related benign proliferation of the epithelial and stromal components of the prostate. Symptomatic BPH is associated with the progressive development of lower urinary tract symptoms (LUTS), which left untreated can deteriorate over time and lead to acute urinary retention, urinary incontinence, recurrent urinary tract infections, and/or obstructive uropathy. Recent Findings Surgical or medical treatment that correct bladder outlet obstruction from BPH in patients generally resolves voiding symptoms and reduces the urine levels of neurotrophins. Histological analysis of the prostate biopsies obtained from BPH patients enrolled in large clinical studies supported the role of prostatic inflammation in BPH/LUTS. However, the invasive nature of biopsy motivates the research in alternative biofluids for the discovery of biomarkers to influence the clinical management of BPH. We recently reported that urinary levels of chemokines are associated with the evidence of prostatic inflammation and measures of obesity in BPH patients. Summary Detection of inflammatory mediators in urine of BPH patients has the potential to displace biopsy for discriminating BPH-related pathologies, identify risk of progressive disease, and personalize the management of BPH-related LUTS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据